3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Achieving no evidence of disease (NED) in HER2-positive metastatic breast cancer (MBC) has been proposed as a surrogate for durable disease control. However, its clinical significance and predictive factors are not yet well established.
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Gastric Cancer Management and Outcomes
Breast Cancer Treatment Studies
Publication details
- Journal / source
- ESMO Open
- Volume
- 11
- Pages
- 106106–106106
- Publication date
- 1 April 2026
- Language
- EN